All current strains of BCG (Bacille Calmette-Guerin) are derived from a strain developed by Leon Calmette and Camille Guerin at the Pasteur Institute, Lille, in the early 20th century (Sakula, 1983). Nocard had isolated a virulent M. bovis strain from a cow with tuberculous mastitis. This bovine strain, “Lait Nocard,” was sent to Calmette (Grange et al., 1983; Oettinger et al., 1999). He and Guerin had been working on bovine tubercle bacilli, that is, M. bovis. Between 1908 and 1921, 230 passages were completed (Corbel et al., 2004). There was an associated decrease in virulence of this strain in different animal species over this period (Sakula, 1983) and administration to humans as a vaccine began in 1921 (Sakula, 1983; Bryder, 1999). Even after this, for more than 10 years controversy raged over whether, in fact, the BCG strain was attenuated. Unfortunately, the original strain was lost during the First World War, and the exact process(es) that led to the attenuation of this M. bovis strain is uncertain (Grange et al., 1983).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc
About this paper
Cite this paper
Teo, S.S.S., Shingadia, D. (2005). BCG Vaccine. In: Pollard, A.J., Finn, A. (eds) Hot Topics in Infection and Immunity in Children II. Advances in Experimental Medicine and Biology, vol 568. Springer, Boston, MA. https://doi.org/10.1007/0-387-25342-4_8
Download citation
DOI: https://doi.org/10.1007/0-387-25342-4_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-25341-1
Online ISBN: 978-0-387-25342-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)